174 related articles for article (PubMed ID: 8371065)
1. On the mechanism of the hypolipidemic effect of sulfur-substituted hexadecanedioic acid (3-thiadicarboxylic acid) in normolipidemic rats.
Skorve J; al-Shurbaji A; Asiedu D; Björkhem I; Berglund L; Berge RK
J Lipid Res; 1993 Jul; 34(7):1177-85. PubMed ID: 8371065
[TBL] [Abstract][Full Text] [Related]
2. Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis.
al-Shurbaji A; Skorve J; Berge RK; Rudling M; Björkhem I; Berglund L
Arterioscler Thromb; 1993 Nov; 13(11):1580-6. PubMed ID: 8218098
[TBL] [Abstract][Full Text] [Related]
3. The hypocholesterolemic effect of sulfur-substituted fatty acid analogues in rats fed a high carbohydrate diet.
Skorve J; Berge RK
Biochim Biophys Acta; 1993 Apr; 1167(2):175-81. PubMed ID: 8466946
[TBL] [Abstract][Full Text] [Related]
4. Alkylthioacetic acids (3-thia fatty acids) as non-beta-oxidizable fatty acid analogues: a new group of hypolipidemic drugs. III. Dissociation of cholesterol- and triglyceride-lowering effects and the induction of peroxisomal beta-oxidation.
Aarsland A; Aarsaether N; Bremer J; Berge RK
J Lipid Res; 1989 Nov; 30(11):1711-8. PubMed ID: 2614273
[TBL] [Abstract][Full Text] [Related]
5. Regulation of fatty acid oxidation and triglyceride and phospholipid metabolism by hypolipidemic sulfur-substituted fatty acid analogues.
Skorve J; Asiedu D; Rustan AC; Drevon CA; al-Shurbaji A; Berge RK
J Lipid Res; 1990 Sep; 31(9):1627-35. PubMed ID: 2174075
[TBL] [Abstract][Full Text] [Related]
6. Hepatic fatty acid metabolism as a determinant of plasma and liver triacylglycerol levels. Studies on tetradecylthioacetic and tetradecylthiopropionic acids.
Asiedu DK; al-Shurbaji A; Rustan AC; Björkhem I; Berglund L; Berge RK
Eur J Biochem; 1995 Feb; 227(3):715-22. PubMed ID: 7867630
[TBL] [Abstract][Full Text] [Related]
7. Enhanced hepatic fatty acid oxidation and upregulated carnitine palmitoyltransferase II gene expression by methyl 3-thiaoctadeca-6,9,12,15-tetraenoate in rats.
Willumsen N; Vaagenes H; Rustan AC; Grav H; Lundquist M; Skattebøl L; Songstad J; Berge RK
J Lipid Mediat Cell Signal; 1997 Nov; 17(2):115-34. PubMed ID: 9459137
[TBL] [Abstract][Full Text] [Related]
8. Alkylthio acetic acids (3-thia fatty acids)--a new group of non-beta-oxidizable peroxisome-inducing fatty acid analogues--II. Dose-response studies on hepatic peroxisomal- and mitochondrial changes and long-chain fatty acid metabolizing enzymes in rats.
Berge RK; Aarsland A; Kryvi H; Bremer J; Aarsaether N
Biochem Pharmacol; 1989 Nov; 38(22):3969-79. PubMed ID: 2574577
[TBL] [Abstract][Full Text] [Related]
9. Acute modulation of rat hepatic lipid metabolism by sulphur-substituted fatty acid analogues.
Asiedu DK; Demoz A; Skorve J; Grav HJ; Berge RK
Biochem Pharmacol; 1995 Mar; 49(7):1013-22. PubMed ID: 7741757
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats.
Willumsen N; Hexeberg S; Skorve J; Lundquist M; Berge RK
J Lipid Res; 1993 Jan; 34(1):13-22. PubMed ID: 8445337
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
Vaziri ND; Liang K; Azad H
J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of tetradecylthioacetic acid: a study on plasma lipid profile and fatty acid composition and oxidation in different rat organs.
Asiedu DK; Frøyland L; Vaagenes H; Lie O; Demoz A; Berge RK
Biochim Biophys Acta; 1996 Apr; 1300(2):86-96. PubMed ID: 8652642
[TBL] [Abstract][Full Text] [Related]
13. Effects of non-beta-oxidizable sulfur-substituted fatty acid analogues on synthesis and secretion of triacylglycerol and cholesterol in cultured rat hepatocytes.
Skorve J; Rustan AC; Berge RK
Lipids; 1995 Nov; 30(11):987-94. PubMed ID: 8569438
[TBL] [Abstract][Full Text] [Related]
14. Effect of n-3 fatty acids on the key enzymes involved in cholesterol and triglyceride turnover in rat liver.
al-Shurbaji A; Larsson-Backström C; Berglund L; Eggertsen G; Björkhem I
Lipids; 1991 May; 26(5):385-9. PubMed ID: 1895886
[TBL] [Abstract][Full Text] [Related]
15. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
[TBL] [Abstract][Full Text] [Related]
16. The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis.
Willumsen N; Skorve J; Hexeberg S; Rustan AC; Berge RK
Lipids; 1993 Aug; 28(8):683-90. PubMed ID: 8377581
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid metabolism in liver of rats treated with hypolipidemic sulphur-substituted fatty acid analogues.
Asiedu D; Aarsland A; Skorve J; Svardal AM; Berge RK
Biochim Biophys Acta; 1990 May; 1044(2):211-21. PubMed ID: 1971517
[TBL] [Abstract][Full Text] [Related]
18. Effect of 3- and 4-thia-substituted fatty acids on glycerolipid metabolism and mitochondrial beta-oxidation in rat liver.
Skorve J; Ruyter B; Rustan AC; Christiansen EN; Drevon CA; Berge RK
Biochem Pharmacol; 1990 Nov; 40(9):2005-12. PubMed ID: 2242030
[TBL] [Abstract][Full Text] [Related]
19. Effect of removal of lipoproteins of different composition on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and hepatic very low density lipoprotein secretion.
Van Zuiden PE; Erickson SK; Cooper AD
J Lipid Res; 1983 Apr; 24(4):418-28. PubMed ID: 6854151
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
Vaziri ND; Sato T; Liang K
Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
